Our ex vivo and in vivo data reveal that the SLC15A4-TASL complex is critical for two of the main pathogenic processes mediating SLE, i.e. IFN and proinflammatory cytokine production by innate immune cells and production of autoantibodies by B cells. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.